Since launching their fashion brand The Row, the Olsen twins have managed that rare celebrity feat of creating a fashion line that is known for superior quality and fit rather than just on-trend looks. And, up until now, the pair have focussed exclusively on creating women's wear. But that's all about to change. In an interview with WSJ Magazine, Mary-Kate and Ashley revealed that they have designed a full menswear collection for the first time, which will focus on beautiful, meticulously-made suits and separates.
A sneak peak of the suits has been added to The Row's website
The former child stars explained that the collection has been in the works for over two years, and they have travelled the world in search of the perfect manufacturers – the shirts will be made in France, the suits in Japan, the knits in Italy and denim and T-shirts in the US. They also asked friends and husbands to try out the pieces as part of the painstakingly researched process. The twins' designs don't come cheap – suits will range in price from $3,950 to $5,795 – but according the label, every piece lasts forever and the quality of the clothes have helped set them apart in a fast fashion-obsessed world.
READ MORE: 10 things you probably didn't know about the Olsen twins
Last year, the twins ended UK consumers' four-year-long wait and finally made their signature fragrances available on British soil. Harrods now exclusively stocks the entire Nirvana line, including Nirvana White, Black, Rose and Bourbon. As well as these original scents, the luxury retailer also has two brand new additions – Amethyst and French Grey.
Discussing their hugely successful clothing and now lifestyle brand, Elizabeth and James, Mary-Kate told Vogue: "The last year has been an exciting time for us. We brought the apparel category in-house and opened our first retail store for the brand in Los Angeles. Expanding international distribution for the fragrances is another important layer to growing the brand on a global scale."
WATCH: HELLO! fashion monthly: Grete Bellamacina
